Skip to main content
. Author manuscript; available in PMC: 2011 Apr 15.
Published in final edited form as: Cancer. 2010 Apr 15;116(8):1918–1925. doi: 10.1002/cncr.24997

Figure 1.

Figure 1

Box plot of preoperative plasma CFDNA (GE/ml) for controls, patients with benign ovarian masses and ovarian carcinoma in the (A) Training Set (n=144) and (B) Validation Set (n=144). CFDNA level is significantly higher in the invasive carcinoma group when compared to women with benign ovarian tumors and controls with normal ovaries in both datasets.